MOE Key Laboratory of Gene Function and Regulation, School of Life Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Int J Mol Sci. 2022 Dec 18;23(24):16155. doi: 10.3390/ijms232416155.
Osteosarcoma (OS) is a malignancy that is becoming increasingly common in adolescents. OS stem cells (OSCs) form a dynamic subset of OS cells that are responsible for malignant progression and chemoradiotherapy resistance. The unique properties of OSCs, including self-renewal, multilineage differentiation and metastatic potential, 149 depend closely on their tumor microenvironment. In recent years, the likelihood of its dynamic plasticity has been extensively studied. Importantly, the tumor microenvironment appears to act as the main regulatory component of OS cell plasticity. For these reasons aforementioned, novel strategies for OS treatment focusing on modulating OS cell plasticity and the possibility of modulating the composition of the tumor microenvironment are currently being explored. In this paper, we review recent studies describing the phenomenon of OSCs and factors known to influence phenotypic plasticity. The microenvironment, which can regulate OSC plasticity, has great potential for clinical exploitation and provides different perspectives for drug and treatment design for OS.
骨肉瘤(OS)是一种在青少年中越来越常见的恶性肿瘤。OS 干细胞(OSCs)形成了 OS 细胞的一个动态亚群,负责恶性进展和放化疗耐药。OSCs 的独特特性,包括自我更新、多能分化和转移潜能,149 密切依赖于其肿瘤微环境。近年来,其动态可塑性的可能性已被广泛研究。重要的是,肿瘤微环境似乎充当了 OS 细胞可塑性的主要调节成分。基于这些原因,目前正在探索针对 OS 治疗的新策略,重点是调节 OS 细胞的可塑性和调节肿瘤微环境组成的可能性。在本文中,我们回顾了描述 OSCs 现象和已知影响表型可塑性的因素的最新研究。肿瘤微环境可以调节 OSCs 的可塑性,具有很大的临床开发潜力,并为 OS 的药物和治疗设计提供了不同的视角。